Surgery for metastatic breast cancer (MBC): Closing the barn door after the horse has bolted?

16^th Global Annual Oncologists Meeting

April 24-25, 2017 Dubai, UAE

Archana Shetty

Kokilaben Dhirubhai Ambani Hospital, INDIA

Posters & Accepted Abstracts: J Cancer Sci Ther

Abstract :

Approximately 4-7% of breast cancer patients present with distant metastases and about 20-30% of early breast cancers (EBC) will eventually metastasize. Although MBC has traditionally been linked with a poor prognosis, advances in management of these patients have greatly improved their survival. However, the optimal management of the local disease has always been controversial and usually performed with a palliative intent. Most of the evidence is retrospective and two prospective trials have failed to show a significant survival benefit with surgery. Potential curative treatment with a multidisciplinary approach can be considered for MBC patients with oligometastasis, who respond to initial systemic therapy. This talk considers the role of surgery in MBC with or without adjuvant therapy in selected patient groups.

Biography :

Email: Deepak.Kr.Chawla@relianceada.com